NORVIR

Compare NORVIR  to:
Compare
Compare

Generic Name for NORVIR

Ritonavir 100mg; soft gel caps; contains alcohol.

Legal Classification:

Rx

Pharmacological Class for NORVIR

HIV protease inhibitor.

Manufacturer of NORVIR

Abbott Laboratories

Indications for NORVIR

HIV infection.

Adult dose for NORVIR

Take with meals. Initially at least 300mg twice daily, increase every 2–3 day by 100mg twice daily to 600mg twice daily. May initiate alone, then add nucleoside analogues before completing 2 weeks of ritonavir monotherapy. Concomitant saquinavir: reduce ritonavir dose to 400mg twice daily.

Children's dosing for NORVIR

Give with food. <2yrs: not recommended. ≥2yrs: initially 250mg/m2 twice daily; increase every 2–3 days by 50mg/m2 twice daily to 400mg/m2 twice daily; max 600mg twice daily.

Also:

Contraindications for NORVIR

Amiodarone, bepridil, flecainide, quinidine, propafenone, ergots, midazolam, triazolam, pimozide, cisapride.

Warnings/Precautions for NORVIR

Discontinue if pancreatitis occurs. Impaired hepatic function, liver enzyme abnormalities, hepatitis; consider monitoring ALT/AST at baseline and for first 3 months of therapy. Monitor blood, triglycerides, cholesterol, and for hyperglycemia. Hemophilia. Diabetes. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions for NORVIR

See Contraindications. Rifampin, lovastatin, simvastatin, St. John's wort, high-dose or long-term meperidine: not recommended. Potentiates sildenafil, vardenafil (reduce sildenafil and vardenafil doses), fluticasone (avoid). May be affected by, potentiate, or antagonize drugs that are metabolized by or induce CYP3A4, 2D6, 2C9, 3A, 1A2 or glucuronyl transferase, including: opioids, antiarrhythmics (eg, disopyramide, mexiletine), macrolides, anticoagulants, anticonvulsants, most antidepressants (eg, SSRIs, tricyclics, nefazodone, bupropion), antiemetics (eg, dronabinol), antihypertensives (eg, calcium channel blockers, β-blockers), antiparasitics, antifungals (eg, itraconazole), corticosteroids, indinavir, saquinavir, sulfonylureas, immunosuppressants, neuroleptics, sedative/hypnotics, CNS stimulants, atorvastatin; monitor these and others closely. Antagonizes theophylline, oral contraceptives, methadone. Separate dosing of didanosine by 2 ½ hours. Avoid metronidazole, disulfiram; ketoconazole >200mg/day. Reduce rifabutin dose by at least 3/4. See literature.

Adverse Reactions for NORVIR

GI upset, asthenia, abdominal pain, headache, anorexia, paresthesias, taste perversion, fever, hyperlipidemia, dizziness, rash, throat irritation, myalgia, somnolence, insomnia, sweating, vasodilation, increased triglycerides, pancreatitis, fat redistribution; others.

Notes for NORVIR

Register pregnant patients exposed to ritonavir by calling (800) 258-4263.

How is NORVIR supplied?

Caps—120
Soln—8oz

Related Disease:

HIV~antivirals

Related Resources

Abbott RealTime HBV test approved

September 02, 2010

Abbott announced that the FDA has approved its RealTime HBV assay for measuring the amount of hepatitis B virus (HBV) in human plasma or serum from individuals chronically infected with HBV.

Longer use of Valcyte for renal transplant patients approved

August 11, 2010

The FDA has approved a longer duration of therapy with Valcyte (valganciclovir, from Genentech) in adult renal transplant patients at high risk for cytomegalovirus (CMV) disease.

Phase 3 study of boceprevir for the treatment of HCV

August 05, 2010

Merck announced the completion and results of its two Phase 3 studies for boceprevir for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection.

Afluria labeling updated to include fever and febrile seizure risk

August 02, 2010

The Prescribing Information for Afluria (trivalent, inactivated, "split virus" influenza vaccine [Types A and B], from CSL Biotherapies) has been updated to inform healthcare professionals of an increased incidence of fever and febrile seizure among young children in Australia, mainly those <5years of age.

Fluzone available for 2010-2011 influenza season

July 30, 2010

Sanofi Pasteur announced that it has begun shipping the 2010-2011 formulation of Fluzone (trivalent inactivated "split virus" influenza vaccine [Types A and B]).

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions